Modular trenches, bunkers, wasteland wreckage, infested ruins, sci-fi vehicles - everything you need for apocalyptic and ...

Trump, who wanted to attend arguments, says it's the "most important" case ever. Back in April, President Donald Trump made his decadeslong view on tariffs the official policy of the United States by ...

In September, hundreds of volunteers with the American Cancer Society Cancer Action Network fanned out across the U.S. Capitol to lobby for a bill requiring Medicare to cover the cost of an ...

GRAIL moves from scientific vision to proven clinical reality, as PATHFINDER 2 confirms that multi-cancer early detection works effectively at scale. Physician and patient adoption is accelerating, ...

Grail is partnering with Samsung to move into Asia. The innovative cancer test maker just got major new sources of funding. Well, Grail makes a multicancer early-detection test called Galleri that ...

Grail (GRAL +7.99%) has soared 80% over the past month. That's an incredible gain in a market that's climbed under 1% over that period as measured by the broader S&P 500 index. So what's happening?

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from GRAIL Inc ( ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's the second big private ...

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s detailing its latest data as it heads to the FDA. Back in June, Grail revealed ...

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a study has found. The Galleri test, which can be given annually and is ...

MENLO PARK, Calif., Oct. 17, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive ...